Long-term outcome after vitrectomy for diabetic macular edema

被引:16
作者
Kralinger, Martina T.
Pedri, Markus
Kralinger, Franz
Troger, Josef
Kieselbach, Gerhard F.
机构
[1] Univ Innsbruck, Sch Med, Dept Ophthalmol, A-6020 Innsbruck, Austria
[2] Univ Innsbruck, Sch Med, Dept Trauma, A-6020 Innsbruck, Austria
关键词
diabetic macular edema; vitrectomy; visual acuity;
D O I
10.1159/000091756
中图分类号
R77 [眼科学];
学科分类号
100212 ;
摘要
Background: To determine the benefit of vitrectomy on eyes with diabetic macular edema. Methods: A retrospective institutional case series was used including 66 patients (69 eyes) who had undergone pars plana vitrectomy for diabetic macular edema between 1992 and 2000. Prior to surgery, the patients had been treated with laser coagulation as recommended by the Early Treatment Diabetic Retinopathy Study. In the case of persistent macular edema, vitrectomy with removal of the posterior hyaloid in all cases and the inner limiting membrane in 51 (74%) of all cases was performed. Results: The mean preoperative best-corrected visual acuity improved from 20/320 to 20/80 at the time of best postoperative best-corrected visual acuity (p < 0.0001). The mean increase in Snellen lines was 2.7 +/- 7.9. In 90% of eyes, the macular edema improved. A persistence of the edema was observed in 10%. All eyes had at least 12 months of follow-up with a mean of 55 months and a maximum of 120 months. Conclusions: Our findings confirm that vitrectomy might represent a therapeutic alternative in the case of persisting diabetic macular edema after laser photocoagulation. Copyright (c) 2006 S. Karger AG, Basel.
引用
收藏
页码:147 / 152
页数:6
相关论文
共 20 条
[1]   Vascular endothelial growth factor-induced retinal permeability is mediated by protein kinase C in vivo and suppressed by an orally effective beta-isoform-selective inhibitor [J].
Aiello, LP ;
Bursell, SE ;
Clermont, A ;
Duh, E ;
Ishii, H ;
Takagi, C ;
Mori, F ;
Ciulla, TA ;
Ways, K ;
Jirousek, M ;
Smith, LEH ;
King, GL .
DIABETES, 1997, 46 (09) :1473-1480
[2]   Vascular permeability in experimental diabetes is associated with reduced endothelial occludin content - Vascular endothelial growth factor decreases occludin in retinal endothelial cells [J].
Antonetti, DA ;
Barber, AJ ;
Khin, S ;
Lieth, E ;
Tarbell, JM ;
Gardner, TW .
DIABETES, 1998, 47 (12) :1953-1959
[3]  
BLANKENSHIP GW, 1979, OPHTHALMOLOGY, V86, P69
[4]  
BRESNICK GH, 1986, OPHTHALMOLOGY, V93, P989
[5]   The natural history of macular edema after cataract surgery in diabetes [J].
Dowler, JGF ;
Sehmi, KS ;
Hykin, PG ;
Hamilton, AMP .
OPHTHALMOLOGY, 1999, 106 (04) :663-668
[6]   Resolution of diabetic macular edema after surgical removal of the posterior hyaloid and the inner limiting membrane [J].
Gandorfer, A ;
Messmer, EM ;
Ulbig, MW ;
Kampik, A .
RETINA-THE JOURNAL OF RETINAL AND VITREOUS DISEASES, 2000, 20 (02) :126-133
[7]   Histamine reduces ZO-1 tight-junction protein expression in cultured retinal microvascular endothelial cells [J].
Gardner, TW ;
Lesher, T ;
Khin, S ;
Vu, C ;
Barber, AJ ;
Brennan, WA .
BIOCHEMICAL JOURNAL, 1996, 320 :717-721
[8]   Vitrectomy for diabetic macular edema associated with a thickened and taut posterior hyaloid membrane [J].
Harbour, JW ;
Smiddy, WE ;
Flynn, HW ;
Rubsamen, PE .
AMERICAN JOURNAL OF OPHTHALMOLOGY, 1996, 121 (04) :405-413
[9]  
IKEDA T, 2000, RETINA, V2, P220
[10]  
KLEIN R, 1984, OPHTHALMOLOGY, V91, P1464